The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy.
Saved in:
| Title: | The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy. |
|---|---|
| Authors: | Kim, S.1, Chen, D.T.1, Stone, B.M.2, Al-Rashdan, A.F.3, Elsaka, R.4, Torres-Roca, J.F.5, Haura, E.1, Dilling, T.J.5, Robinson, L.1, Stevens, C.W.2 |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pS67-S67. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
